Tower Research Capital (TRC)’s iShares US Medical Devices ETF IHI Stock Holding History

Tower Research Capital (TRC)’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,370	Closed	-$1.41M	–	5441
2026 Q1	$1.41M	Sell	26,370 -32,646	-55%	-$1.92M	0.04%	441
2025 Q4	$3.67M	Buy	59,016 +26,555	+82%	+$1.64M	0.09%	200
2025 Q3	$1.95M	Sell	32,461 -4,193	-11%	-$256K	0.05%	299
2025 Q2	$2.3M	Sell	36,654 -19,571	-35%	-$1.18M	0.06%	283
2025 Q1	$3.63M	Buy	56,225 +7,553	+16%	+$469K	0.11%	155
2024 Q4	$2.84M	Buy	48,672 +11,723	+32%	+$697K	0.06%	277
2024 Q3	$2.19M	Buy	36,949 +22,686	+159%	+$1.3M	0.06%	256
2024 Q2	$799K	Sell	14,263 -24,149	-63%	-$1.35M	0.01%	940
2024 Q1	$2.25M	Sell	38,412 -27,397	-42%	-$1.55M	0.05%	254
2023 Q4	$3.55M	Buy	65,809 +53,242	+424%	+$2.6M	0.04%	341
2023 Q3	$610K	Buy	12,567 +6,017	+92%	+$320K	0.02%	764
2023 Q2	$370K	Sell	6,550 -74,171	-92%	-$4.09M	0.01%	1166
2023 Q1	$4.36M	Buy	80,721 +12,324	+18%	+$656K	0.14%	92
2022 Q4	$3.6M	Buy	68,397 +68,393	+1,709,825%	+$3.47M	0.15%	87
2022 Q3	$0	Sell	4 -41,142	-100%	-$2.13M	﹤0.01%	6258
2022 Q2	$2.08M	Buy	41,146 +13,078	+47%	+$713K	0.05%	362
2022 Q1	$1.71M	Buy	28,068 +28,060	+350,750%	+$1.67M	0.02%	608
2021 Q4	$1K	Sell	8 -28,871	-100%	-$1.85M	﹤0.01%	5834
2021 Q3	$1.81M	Sell	28,879 -17,003	-37%	-$1.08M	0.05%	292
2021 Q2	$2.76M	Sell	45,882 -122,970	-73%	-$7.11M	0.07%	212
2021 Q1	$9.3M	Buy	168,852 +132,768	+368%	+$7.36M	0.16%	114
2020 Q4	$1.97M	Sell	36,084 -144,330	-80%	-$7.54M	0.06%	234
2020 Q3	$9.01M	Buy	180,414 +64,596	+56%	+$3.13M	0.1%	30
2020 Q2	$5.11M	Buy	115,818 +71,748	+163%	+$3.07M	0.21%	67
2020 Q1	$1.66M	Buy	+44,070	New	+$1.86M	0.1%	124
2019 Q4	–	Sell	-1,200	Closed	-$49K	–	3904
2019 Q3	$49K	Buy	1,200 +582	+94%	+$23.8K	﹤0.01%	1817
2019 Q2	$25K	Sell	618 -88,404	-99%	-$3.35M	﹤0.01%	2027
2019 Q1	$3.44M	Sell	89,022 -98,568	-53%	-$3.58M	0.21%	65
2018 Q4	$6.25M	Buy	187,590 +87,462	+87%	+$3.03M	0.45%	31
2018 Q3	$3.8M	Sell	100,128 -113,982	-53%	-$4.05M	0.28%	55
2018 Q2	$7.16M	Buy	214,110 +28,560	+15%	+$930K	0.4%	43
2018 Q1	$5.72M	Buy	185,550 +97,662	+111%	+$3.01M	0.49%	27
2017 Q4	$2.54M	Sell	87,888 -89,262	-50%	-$2.57M	0.33%	53
2017 Q3	$4.93M	Buy	177,150 +26,136	+17%	+$723K	0.41%	35
2017 Q2	$4.19M	Sell	151,014 -510	-0.3%	-$13.5K	0.48%	32
2017 Q1	$3.82M	Buy	+151,524	New	+$3.67M	0.38%	29
2016 Q3	–	Sell	-175,488	Closed	-$3.96M	–	4006
2016 Q2	$3.96M	Sell	175,488 -135,900	-44%	-$2.94M	0.38%	41
2016 Q1	$6.36M	Buy	+311,388	New	+$6.05M	0.95%	16
2015 Q4	–	Sell	-18,684	Closed	-$347K	–	4732
2015 Q3	$347K	Sell	18,684 -12,426	-40%	-$250K	0.03%	194
2015 Q2	$621K	Sell	31,110 -142,806	-82%	-$2.86M	0.06%	124
2015 Q1	$3.49M	Buy	173,916 +11,880	+7%	+$232K	0.43%	23
2014 Q4	$3.06M	Buy	+162,036	New	+$2.92M	0.3%	53
2014 Q3	–	Sell	-70,110	Closed	-$1.19M	–	4625
2014 Q2	$1.19M	Buy	+70,110	New	+$1.15M	0.15%	72
2014 Q1	–	Sell	-168,342	Closed	-$2.6M	–	4660
2013 Q4	$2.6M	Buy	+168,342	New	+$2.51M	0.43%	38

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Tower Research Capital (TRC)'s IHI Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 26,370 shares — an estimated $1.41M sold.

Tower Research Capital (TRC) first reported a position in IHI in Q4 2013 and held it in 44 quarters. The position peaked at $9.3M in Q1 2021. 504 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Tower Research Capital (TRC) reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 26,370 iShares US Medical Devices ETF shares in Q2 2026, an estimated $1.41M.
Tower Research Capital (TRC) first reported a position in iShares US Medical Devices ETF in Q4 2013 and held it in 44 quarters.
Tower Research Capital (TRC)'s iShares US Medical Devices ETF position peaked at $9.3M in Q1 2021.
504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.